why is NVS R&D a revolving door?

Quote












Here's why: you are somewhere else, a rising star, and you keep hearing about how great Novartis is. It's such a solid company, great sales, great science, big pipeline. Then there's an opportunity to come to Novartis and you jump at it. The pay isn't so great, but hey the company is! And plus you'll just be happy doing great research. Then you go to your first Sr. Management meeting and you see how things work. Your smile begins to fade like a parched rose as you have to answer questions from idiot yes-men. Nearly all of whom are German for some reason. Again and again, decisions are made in back offices and offsite "meetings" to which you were not invited. You begin to see the culture of sycophants that exists, and you realize it overlies a deep rooted culture of fear. You remember that you really aren't getting paid all that well, and the pipeline is actually full of duds and me-too's, and as you look around the room you say to yourself, "I wouldn't invite a single one of these dopes over to my house for dinner. I gotta get out of this place."
 


















Alcon employee here. Sounds about the same as we are experiencing since Novartis took over. Are you guys in Jersey? I'm just wondering because if anything is positive about Alcon is that we do make a pretty good salary but the cost of living in Texas is much lower than other areas of the country so sometimes it's hard to compare. I hope it gets better for you guys but I doubt it will. Seems like the house of cards is falling quickly.
 






Former R&D Scientist here.

You want to know why R&D is a revolving door. Because management has "strategically" moved away from data moving research forward to numbers (ie. compounds and program transitions).

I was in a key growth area, but instead of spending the cash for understanding why a series of compounds had exciting activity in vivo, it was abandoned and a poorer compound was pushed forward because we had made ~250 analogs vs. ~50 from the interesting series.

Also, R&D scientists have learned that all the people with actual experience moving novel drugs to market have been canned over the past year. Now, there is simply a void for those with "ambition" and no insight to fill that role.
 






Anonymous said:
Here's why: you are somewhere else, a rising star, and you keep hearing about how great Novartis is. It's such a solid company, great sales, great science, big pipeline. Then there's an opportunity to come to Novartis and you jump at it. The pay isn't so great, but hey the company is! And plus you'll just be happy doing great research. Then you go to your first Sr. Management meeting and you see how things work. Your smile begins to fade like a parched rose as you have to answer questions from idiot yes-men. Nearly all of whom are German for some reason. Again and again, decisions are made in back offices and offsite "meetings" to which you were not invited. You begin to see the culture of sycophants that exists, and you realize it overlies a deep rooted culture of fear. You remember that you really aren't getting paid all that well, and the pipeline is actually full of duds and me-too's, and as you look around the room you say to yourself, "I wouldn't invite a single one of these dopes over to my house for dinner. I gotta get out of this place."
Click to expand...

you have nailed it!
 






Top Bottom
Back
Quote